Symcel Company
Symcel develops and markets analytical instrumentations that fulfil an unmet need for cell biological research and development
Founded Date:
2004
Total Funding:
€946K
Investor Type:
For Profit
Employee Number:
1-10
Technology:
Cancer
Last Funding Type:
Seed
Industry:
PharmTech
Headquarters:
SpРЄnga, Skane Lan, Sweden
Estimated Revenue:
Less than $1M